Related references
Note: Only part of the references are listed.Combination of metformin and chlorogenic acid attenuates hepatic steatosis and inflammation in high-fat diet fed mice
Fahimeh Zamani-Garmsiri et al.
IUBMB LIFE (2021)
Protective Effects of Polyphenol Enriched Complex Plants Extract on Metabolic Dysfunctions Associated with Obesity and Related Nonalcoholic Fatty Liver Diseases in High Fat Diet-Induced C57BL/6 Mice
Ahtesham Hussain et al.
MOLECULES (2021)
Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects
Qichao Hu et al.
PHARMACOLOGICAL RESEARCH (2021)
Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway
Chuangpeng Shen et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways
Yanyan Wang et al.
CELLS (2021)
Protective effect of the new prepared Atractylodes macrocephala Koidz polysaccharide on fatty liver hemorrhagic syndrome in laying hens
Y. F. Miao et al.
POULTRY SCIENCE (2021)
Quercetin prevents cadmium chloride-induced hepatic steatosis and fibrosis by downregulating the transcription of miR-21
Ghedeir M. Alshammari et al.
BIOFACTORS (2021)
Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease
Honglin Zhou et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Therapeutic potential of puerarin against methionine-choline-deficient diet-induced non-alcoholic steatohepatitis determined by combination of 1H NMR spectroscopy-based metabonomics and 16S rRNA gene sequencing
Meng-juan Gong et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2021)
Geniposide and Chlorogenic Acid Combination Improves Non-Alcoholic Fatty Liver Disease Involving the Potent Suppression of Elevated Hepatic SCD-1
Cheng Chen et al.
FRONTIERS IN PHARMACOLOGY (2021)
SIRT1 provides new pharmacological targets for polydatin through its role as a metabolic sensor
Zhicheng Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Polysaccharide of Atractylodes macrocephala Koidz regulates LPS-mediated mouse hepatitis through the TLR4-MyD88-NFκB signaling pathway
Sixuan Guo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
Effects of phytosomal curcumin on anthropometric parameters, insulin resistance, cortisolemia and non-alcoholic fatty liver disease indices: a double-blind, placebo-controlled clinical trial
Arrigo F. G. Cicero et al.
EUROPEAN JOURNAL OF NUTRITION (2020)
Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model
Runbin Sun et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice
Jin Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages
Beibei Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Glycyrrhetinic acid attenuates disturbed vitamin a metabolism in non-alcoholic fatty liver disease through AKR1B10
Lei Shi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis
Weijian Mai et al.
FRONTIERS IN PHARMACOLOGY (2020)
Baicalin attenuates hepatic injury in non-alcoholic steatohepatitis cell model by suppressing inflammasome-dependent GSDMD-mediated cell pyroptosis
Huilian Shi et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
From NAFLD to MAFLD: when pathophysiology succeeds
Herbert Tilg et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Vitexin ameliorates chronic stress plub high fat diet-induced nonalcoholic fatty liver disease by inhibiting inflammation
Chujie Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Activation of estrogen receptor α (ERα) is required for Alisol B23-acetate to prevent post-menopausal atherosclerosis and reduced lipid accumulation
Qi Chen et al.
LIFE SCIENCES (2020)
Phytochemistry and Pharmacological Activities ofWolfiporia cocos (FA Wolf) Ryvarden & Gilb
Anzheng Nie et al.
FRONTIERS IN PHARMACOLOGY (2020)
Activation of the AMPK-SIRT1 pathway contributes to protective effects of Salvianolic acid A against lipotoxicity in hepatocytes and NAFLD in mice
Songtao Li et al.
FRONTIERS IN PHARMACOLOGY (2020)
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
Arun J. Sanyal et al.
HEPATOLOGY (2019)
Alisol A attenuates high-fat-diet-induced obesity and metabolic disorders via the AMPK/ACC/SREBP-1c pathway
Chiakang Ho et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Therapeutic effects of curcumin and ursodexycholic acid on non-alcoholic fatty liver disease
Shahsanam Gheibi et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Maslinic acid protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/AMPK signaling pathway
Chian-Jiun Liou et al.
FASEB JOURNAL (2019)
Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway
Xiaopeng Zhu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice
Hao Yang et al.
PHYTOTHERAPY RESEARCH (2019)
Vitexin alleviates non-alcoholic fatty liver disease by activating AMPK in high fat diet fed mice
Shrirang Inamdar et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Wogonin attenuates liver fibrosis via regulating hepatic stellate cell activation and apoptosis
Xiao-Sa Du et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4/NF-κB signaling pathway in mice
Beibei Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients
Alessandro Federico et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)
Altilix® Supplement Containing Chlorogenic Acid and Luteolin Improved Hepatic and Cardiometabolic Parameters in Subjects with Metabolic Syndrome: A 6 Month Randomized, Double-Blind, Placebo-Controlled Study
Giuseppa Castellino et al.
NUTRIENTS (2019)
A pilot study of the effect of phospholipid curcumin on serum metabolomic profile in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial
Saeed Chashmniam et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2019)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Anthraquinone and naphthopyrone glycosides from Cassia obtusifolia seeds mediate hepatoprotection via Nrf2-mediated HO-1 activation and MAPK modulation
Pradeep Paudel et al.
ARCHIVES OF PHARMACAL RESEARCH (2018)
Curcumin regulates endogenous and exogenous metabolism via Nrf2-FXR-LXR pathway in NAFLD mice
Caixia Yan et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy
Mariel F. van Stee et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Alisol A 24-acetate ameliorates nonalcoholic steatohepatitis by inhibiting oxidative stress and stimulating autophagy through the AMPK/mTOR pathway
Chenqu Wu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Glycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation
Tingting Yan et al.
DRUG METABOLISM AND DISPOSITION (2018)
Silybin inhibits NLRP3 inflammasome assembly through the NAD+/SIRT2 pathway in mice with nonalcoholic fatty liver disease
Bangling Zhang et al.
FASEB JOURNAL (2018)
Chlorogenic acid alleviates autophagy and insulin resistance by suppressing JNK pathway in a rat model of nonalcoholic fatty liver disease
Hua Yan et al.
JOURNAL OF BIOSCIENCES (2018)
Curcumin inhibits hepatic stellate cell activation via suppression of succinate-associated HIF-1α induction
Linlin She et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2018)
Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From two hit theory to multiple hit model
Yan-Lan Fang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Astragaloside IV Inhibits Adipose Lipolysis and Reduces Hepatic Glucose Production via Akt Dependent PDE3B Expression in HFD-Fed Mice
Qun Du et al.
FRONTIERS IN PHYSIOLOGY (2018)
Polydatin attenuates diet-induced nonalcoholic steatohepatitis and fibrosis in mice
Rui Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
The traditional uses, phytochemistry, and pharmacology of Atractylodes macrocephala Koidz.: A review
Bo Zhu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Catalase and nonalcoholic fatty liver disease
Su-Kyung Shin et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2018)
Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells
Yan Jia et al.
REDOX BIOLOGY (2018)
Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016
Donghee Kim et al.
GASTROENTEROLOGY (2018)
Isoquercetin Improves Hepatic Lipid Accumulation by Activating AMPK Pathway and Suppressing TGF-β Signaling on an HFD-Induced Nonalcoholic Fatty Liver Disease Rat Model
Guohong Qin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Toralactone glycoside in Cassia obtusifolia mediates hepatoprotection via an Nrf2-dependent anti-oxidative mechanism
Yongtaek Seo et al.
FOOD RESEARCH INTERNATIONAL (2017)
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation
David Porras et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
Astragalus membranaceus-Polysaccharides Ameliorates Obesity, Hepatic Steatosis, Neuroinflammation and Cognition Impairment without Affecting Amyloid Deposition in Metabolically Stressed APPswe/PS1dE9 Mice
Yung-Cheng Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
A Biomedical Investigation of the Hepatoprotective Effect of Radix salviae miltiorrhizae and Network Pharmacology-Based Prediction of the Active Compounds and Molecular Targets
Ming Hong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency
Myungsuk Kim et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2017)
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Anna M. Diehl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-alcoholic Steatohepatitis
Veronica Marin et al.
NUTRIENTS (2017)
Effects of Natural Products on Fructose-Induced Nonalcoholic Fatty Liver Disease (NAFLD)
Qian Chen et al.
NUTRIENTS (2017)
Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications
Liang Shen et al.
FOOD & NUTRITION RESEARCH (2017)
Baicalin protects AML-12 cells from lipotoxicity via the suppression of ER stress and TXNIP/NLRP3 inflammasome activation
Junli Zhang et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Wogonin mitigates nonalcoholic fatty liver disease via enhancing PPARα/AdipoR2, in vivo and in vitro
Jing Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Therapeutic potential of Rhizoma Alismatis: a review on ethnomedicinal application, phytochemistry, pharmacology, and toxicology
Le-Le Zhang et al.
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2017)
Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats
Wenhuan Feng et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2017)
Astragaloside IV attenuates free fatty acid-induced ER stress and lipid accumulation in hepatocytes via AMPK activation
Bing Zhou et al.
ACTA PHARMACOLOGICA SINICA (2017)
Non-alcoholic fatty liver disease
Brent A. Neuschwander-Tetri
BMC MEDICINE (2017)
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus A Randomized Trial
Kenneth Cusi et al.
ANNALS OF INTERNAL MEDICINE (2016)
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
Timothy Hardy et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
Rhein lysinate decreases inflammation and adipose infiltration in KK/HlJ diabetic mice with non-alcoholic fatty liver disease
Jie Wei et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
Alisol A 24-Acetate Prevents Hepatic Steatosis and Metabolic Disorders in HepG2 Cells
Lu Zeng et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Polyphenols from hawthorn peels and fleshes differently mitigate dyslipidemia, inflammation and oxidative stress in association with modulation of liver injury in high fructose diet-fed mice
Xiao Han et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease
Xinxia Chang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Emodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics
Xiaoxv Dong et al.
PHYTOTHERAPY RESEARCH (2016)
Astragaloside IV improves lipid metabolism in obese mice by alleviation of leptin resistance and regulation of thermogenic network
Hui Wu et al.
SCIENTIFIC REPORTS (2016)
New insights into salvianolic acid A action: Regulation of the TXNIP/NLRP3 and TXNIP/ChREBP pathways ameliorates HFD-induced NAFLD in rats
Chunchun Ding et al.
SCIENTIFIC REPORTS (2016)
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes
Aijaz Ahmed et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes
Ok-Hwa Kang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
Hong-Mei Yan et al.
PLOS ONE (2015)
Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis
Qiang Meng et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis
Ying-Chun Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease
Wenjing Zeng et al.
SCIENTIFIC REPORTS (2015)
Biological activities and potential health benefits of polysaccharides from Poria cocos and their derivatives
Yichun Sun
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2014)
Botany, phytochemistry, pharmacology, and potential application of Polygonum cuspidatum Sieb.et Zucc.: A review
Wei Peng et al.
JOURNAL OF ETHNOPHARMACOLOGY (2013)
Polydatin: A review of pharmacology and pharmacokinetics
Qiao-Hui Du et al.
PHARMACEUTICAL BIOLOGY (2013)
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial
Carmela Loguercio et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: Analysis of isolated hepatic stellate cells
Mina Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)
Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis
Ke-Qing Shi et al.
MOLECULAR BIOLOGY REPORTS (2012)
The Efficacy of Licorice Root Extract in Decreasing Transaminase Activities in Non-alcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial
Ali Akbar Hajiaghamohammadi et al.
PHYTOTHERAPY RESEARCH (2012)
Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice
Xiaoyan Sheng et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients
Arpita Chakraborty et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Chemical Constituents and Pharmacological Properties of Poria cocos
Jose-Luis Rios
PLANTA MEDICA (2011)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Prevention of free fatty acid-induced hepatic lipotoxicity by 18 beta-glycyrrhetinic acid through lysosomal and mitochondrial pathways
Xudong Wu et al.
HEPATOLOGY (2008)
Share Paper
